Download PDF
Thromb Haemost 1961; 6(03): 498-503
DOI: 10.1055/s-0038-1654581
Originalarbeiten — Original Articles — Travaux Originaux
Schattauer GmbH

On the Behaviour of a Human Serum Proactivator Reacting with Streptokinase during Artificial Activation of the Fibrinolytic System

W Doleschel
1   Department of Physiology (Director: Prof. G. Schubert) University of Vienna, School of Medicine
,
W Auerswald
1   Department of Physiology (Director: Prof. G. Schubert) University of Vienna, School of Medicine
› Author Affiliations
Further Information

Publication History

Publication Date:
12 July 2018 (online)

    Permissions and Reprints

Summary

During “spontaneous” activation of a human euglobulin preparation in suitably spaced samples — while plasminogen became progressively converted into piasmin — the proactivator content was tested by addition of equal amounts of streptokinase and evaluation of the lytic activities on heated and normal bovine fibrin plates. Indepedently of the decreasing content of plasminogen the proactivator which could be activated by streptokinase showed no significant change of concentration. These observation indicate that plasminogen is not acting as proactivator and that there exists a separate proactivator-activator system of the fibrinolytic mechanism in human serum.

 

  • Literatur

  • (1) Albrechtsen O. K, Storm O, Claassen M. Fibrinolytic Activity in some Human Body Fluids. Scand. J. clin. Lab. Invest. 10: 310 1958;
    CrossrefPubMedGoogle Scholar
  • (2) Albrechtsen O. K, Thaysen J. H. Fibrinolytic Activity in Human Saliva. Acta physiol. scand. 35: 138 1955;
    CrossrefPubMedGoogle Scholar
  • (3) Astrup T, Sterndorff I. A Fibrinolytic System in Human Milk. Proc. Soc. exp. Biol. (N.Y.) 84: 605 1953;
    CrossrefPubMedGoogle Scholar
  • (4) Auerswald W, Doleschel W. Zur Frage der Beständigkeit humaner fibrino-lytisch aktiver Substanzen bei neutralem pH in Abhängigkeit von der Ionenstärke. Med. exp. 2: 42 1960;
    PubMedGoogle Scholar
  • (5) Auerswald W, Doleschel W. Critical Evaluation of the Fibrin Plate Method for Estimating Fibrinolytic Enzymes and Activators. Thromb. Diath. haem. 5: 112 1960;
    PubMedGoogle Scholar
  • (6) Doleschel W, Auerswald W. Untersuchungen über die Spontanaktivierung von humanem Plasminogen in Gegenwart hoher Salzkonzentrationen. Med. exp. 2: 339 1960;
    PubMedGoogle Scholar
  • (7) Doleschel W, Auerswald W. Physiko-chemische Untersuchungen an humaner Urokinase mit besonderer Berücksichtigung ihres Verhaltens gegenüber Adsorbenzien. Wien. Z. inn. Med. 41: 49 1960;
    PubMedGoogle Scholar
  • (8) Doleschel W, Auerswald W. On the Rôle of Human Serum Plasminogen Activator During “Spontaneous” Activation of the Fibrinolytic System. Thromb. Diath. haem. 6: 45 1961;
    PubMedGoogle Scholar
  • (9) Kline D. L, Fishman J. B. Plasmin: The Humoral Protease. Ann. N. Y. Acad. Sci. 68: 25 1957;
    CrossrefPubMedGoogle Scholar
  • (10) Müllertz S. Activation of Plasminogen. Ann. N. Y. Acad. Sci. 68: 38 1957;
    CrossrefPubMedGoogle Scholar
  • (11) Müllertz S, Lassen M. An Activator System in Blood Indispensable for Formation of Plasmin by Streptokinase. Proc. Soc. exp. Biol. (N. Y.) 82: 264 1953;
    CrossrefPubMedGoogle Scholar
  • (12) Remmert L. F, Cohen P. P. Partial Purification and Properties of a Proteolytic Enzyme of Human Serum. J. biol. Chem. 181: 431 1949;
    PubMedGoogle Scholar
  • (13) Sherry S. The Fibrinolytic Activity of Streptokinase Activated Human Plasmin. J. clin. Invest. 33: 1054 1954;
    CrossrefPubMedGoogle Scholar
  • (14) Storm O. Fibrinolytic Activity in Human Tears. Scand. J. clin. Lab. Invest. 7: 55 1955;
    CrossrefPubMedGoogle Scholar
  • (15) Troll W, Sherry S. The Activation of Human Plasminogen by Streptokinase. J. biol. Chem. 213: 881 1955;
    PubMedGoogle Scholar